MYH7 rs17009769: Genetics, Heart Health, and Evidence
The genetic variant rs17009769 is a single nucleotide polymorphism located within the MYH7 gene on chromosome 14. This coding locus has been curated in genomic archives like ClinVar due to historical evaluations regarding genetic predisposition to familial hypertrophic cardiomyopathy. However, modern scientific evidence linking this specific variant to monogenic cardiac disease remains limited, with population frequencies suggesting it represents a benign or low-penetrance background allele.
What each genotype means
Typical risk profile
You carry two copies of the common C allele for this MYH7 variant. This is the predominant genotype observed in the general population and is not associated with an increased predisposition to hypertrophic cardiomyopathy. Having this baseline genotype does not alter your underlying cardiovascular risk from this specific marker.
Carried by approximately 90% of individuals worldwide, representing the vast majority across all major ancestral populations.
Uncertain significance carrier
You carry one copy of the T alternate allele in the MYH7 gene. Although certain MYH7 alterations cause familial hypertrophic cardiomyopathy, this specific variant occurs at a population frequency (~5%) generally considered too high for a classic severe dominant cardiac mutation, leading expert databases like ClinVar to classify it primarily as benign, likely benign, or a variant of uncertain significance. Research evidence for an independent disease-causing role remains limited, and carrying this genotype alone is not diagnostic of heart disease.
Carried by roughly 9% to 10% of individuals across diverse global populations.
Homozygous alternate genotype
You carry two copies of the T allele for this MYH7 variant. While homozygous carriage is uncommon, high-penetrance cardiomyopathy-causing variants in MYH7 are typically far rarer in the general population. Clinical curation currently regards this variant with limited evidence of disease causation, and current research does not indicate this genotype causes cardiomyopathy on its own.
Carried by fewer than 1 in 300 individuals (approximately 0.2% to 0.3%) globally.
Understanding rs17009769 and Its Genomic Context
The single nucleotide polymorphism designated rs17009769 is an established genetic marker situated on human chromosome 14 inside the MYH7 gene. In genomic databases such as dbSNP and Ensembl, it corresponds to a single-base transition involving the forward-strand alleles C and T. Because it resides in a protein-coding sequence, alterations at this locus can influence the primary amino acid sequence of the resulting motor protein. Genetic testing panels frequently capture this site due to its presence in a high-priority cardiovascular gene. Unlike severe structural disruptions or truncating frameshifts, single nucleotide variations like rs17009769 must be carefully weighed in context of their evolutionary conservation and background frequency across global cohorts.
The Biological Function of the MYH7 Gene
The MYH7 gene provides instructions for producing the beta-cardiac myosin heavy chain protein, a vital molecular motor of the sarcomere. As outlined by MedlinePlus Genetics, this motor protein is abundantly expressed in human cardiac muscle, particularly within the ventricles, as well as in slow-twitch type I skeletal muscle fibers. Myosin acts in concert with actin filaments, using energy released from adenosine triphosphate hydrolysis to drive mechanical muscle contraction. Pathogenic variants in MYH7 frequently alter contractile force or biophysical velocity, serving as a primary contributor to inherited cardiomyopathy conditions such as familial hypertrophic cardiomyopathy and dilated cardiomyopathy.
Clinical Evidence and Association Strength
Historically, variations within MYH7 have been heavily curated in repositories like ClinVar due to the gene's known involvement in familial hypertrophic cardiomyopathy. However, modern variant curation frameworks established by ClinGen and the American College of Medical Genetics emphasize that not all coding alterations in disease genes cause disease. For rs17009769, empirical clinical evidence linking it as a primary monogenic cause of severe cardiomyopathy is considered limited. Its presence in healthy population cohorts indicates that it does not demonstrate the high penetrance typical of severe classical mutations, meaning any observed disease correlation is modest, uncertain, or possibly coincidental.
Population Distribution and Frequency Data
A critical piece of evidence in clinical variant classification is allele frequency in unselected population databases like the Genome Aggregation Database (gnomAD). In global datasets, the minor allele at rs17009769 exhibits an overall frequency of approximately 0.0489 (nearly 5 percent). Under standard genetic interpretation guidelines, variants with frequencies approaching or exceeding several percent are far more prevalent than rare, high-penetrance monogenic cardiomyopathy alleles. This substantial prevalence across healthy reference cohorts strongly supports the view that the variant is either benign or represents a common background polymorphism rather than a solitary driver of familial disease.
Navigating Results: What This Genetic Information Means
Finding rs17009769 on a personal genetic report should be approached with realistic scientific perspective. Because the evidence connecting this specific variant directly to disease risk is limited, carrying an alternate allele is not a clinical diagnosis of hypertrophic cardiomyopathy or any other cardiovascular disorder. Direct-to-consumer genetic panels cannot replace formal diagnostic tools such as family pedigree analysis, echocardiography, or clinical-grade multigene testing. Individuals with personal symptoms such as syncope, chest discomfort, or a significant family history of cardiomyopathy should discuss their findings with a board-certified genetic counselor or cardiologist for comprehensive evaluation.
How common is this variant?
The minor allele at rs17009769 has an observed frequency of approximately 0.0489 (around 4.9%) across global cohorts in the Genome Aggregation Database (gnomAD). This indicates that nearly 9 to 10 percent of individuals carry at least one copy of the variant allele.
Frequently asked questions
Does carrying rs17009769 mean I will develop hypertrophic cardiomyopathy?
No. The scientific evidence connecting rs17009769 directly to cardiomyopathy is limited, and the variant is relatively common in healthy reference populations. Having this genetic marker does not constitute a medical diagnosis and is not sufficient on its own to cause disease.
What is the biological function of the MYH7 gene?
MYH7 encodes the beta-cardiac myosin heavy chain protein, which powers the contraction of cardiac muscle and slow-twitch skeletal muscle. It plays a foundational role in ventricular pumping and muscle mechanical function.
Why is rs17009769 listed in ClinVar if evidence is limited?
ClinVar serves as an open archival database where clinical testing laboratories and research groups deposit variant interpretations from patient testing over time. Entries often reflect historic candidate variants or ambiguous findings that continue to be refined as population database sizes grow.
Can commercial consumer genetic tests diagnose heart disease?
No, commercial consumer tests are not intended for clinical diagnostic purposes. A clinical evaluation of heart health requires medical-grade multi-gene sequencing, personal health assessments, family history reviews, and imaging tests like an echocardiogram.
What should I do if I have a family history of cardiomyopathy?
If you or your relatives have experienced unexplained heart failure, fainting, or sudden cardiac events, you should consult a cardiologist or genetic counselor. They can arrange appropriate diagnostic imaging and specialized diagnostic genetic panels.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17009769?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29